Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epidemic Meningitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00474526
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Who this might be right for
Meningitis, Meningococcal
Novartis Vaccines 4,545
Testing effectiveness (Phase 2)Study completedNCT03433482
What this trial is testing

Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,707
Large-scale testing (Phase 3)Looking for participantsNCT07505836
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 1,040
Testing effectiveness (Phase 2)Study completedNCT00297817
What this trial is testing

Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 203
Early research (Phase 1)Study completedNCT01889836
What this trial is testing

Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos

Who this might be right for
Meningitis, Meningococcal, Serogroup C
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 60
Large-scale testing (Phase 3)Study completedNCT01423084
What this trial is testing

Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis 344
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Not applicableActive Not RecruitingNCT06922474
What this trial is testing

Molecular Epidemiology of Enteroviruses Detected at the Virology Laboratory of Brest University Hospital During the Period 2018-2024: Retrospective Analysis of an Atypical Meningitis Epidemic in 2024 (BrEcho9Men)

Who this might be right for
Enterovirus InfectionsMeningitis, ViralMeningitis Enterovirus+1 more
University Hospital, Brest 270
Testing effectiveness (Phase 2)Study completedNCT01732627
What this trial is testing

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections+1 more
Sanofi Pasteur, a Sanofi Company 301
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Testing effectiveness (Phase 2)Study completedNCT00355121
What this trial is testing

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

Who this might be right for
Meningococcal MeningitisTetanusDiphtheria+2 more
Sanofi 882
Post-approval studies (Phase 4)Study completedNCT01424644
What this trial is testing

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Who this might be right for
Meningococcal Meningitis
Novartis 801
Large-scale testing (Phase 3)Study completedNCT03964012
What this trial is testing

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Who this might be right for
Meningococcal Meningitis
Serum Institute of India Pvt. Ltd. 1,800
Post-approval studies (Phase 4)Study completedNCT02724046
What this trial is testing

Ciprofloxacin for the Prevention of Meningococcal Meningitis

Who this might be right for
Meningitis, Meningococcal
Epicentre 300
Not applicableStudy completedNCT01452464
What this trial is testing

Safety of MenACWY-CRM Vaccination in Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 55,397
Not applicableNot Yet RecruitingNCT07671014
What this trial is testing

Metagenomic Analysis of the Pharynx in High Risk Partners

Who this might be right for
GonorrheaNeisseria GonorrheaNeisseria Meningitidis+1 more
Guy's and St Thomas' NHS Foundation Trust 100
Testing effectiveness (Phase 2)Study completedNCT01897402
What this trial is testing

Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 525
Large-scale testing (Phase 3)Study completedNCT03621670
What this trial is testing

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,196
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Testing effectiveness (Phase 2)Study completedNCT00700635
What this trial is testing

Dose Comparison Study of Menactra® in US Children

Who this might be right for
MeningitisMeningococcal InfectionNeisseria Meningitidis
Sanofi Pasteur, a Sanofi Company 333
Next Page